Your browser doesn't support javascript.
loading
Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
Ali, Naveed; Tomlinson, Benjamin; Metheny, Leland; Goldstein, Steven C; Fu, Pingfu; Cao, Shufen; Caimi, Paolo; Patel, Rushang D; Varela, Juan Carlos; Andrade, Luisa; Balls, Jason W; Baer, Linda; Smith, Megan; Smith, Tori; Nelson, Megan; de Lima, Marcos; Mori, Shahram.
Afiliação
  • Ali N; Stem Cell Transplant Program, University Hospitals of Cleveland Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Tomlinson B; Stem Cell Transplant Program, University Hospitals of Cleveland Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Metheny L; Stem Cell Transplant Program, University Hospitals of Cleveland Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Goldstein SC; Department of Blood and Marrow Transplant, AdventHealth Hospital, Orlando, FL, USA.
  • Fu P; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • Cao S; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • Caimi P; Stem Cell Transplant Program, University Hospitals of Cleveland Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Patel RD; Department of Blood and Marrow Transplant, AdventHealth Hospital, Orlando, FL, USA.
  • Varela JC; Department of Blood and Marrow Transplant, AdventHealth Hospital, Orlando, FL, USA.
  • Andrade L; Stem Cell Transplant Program, University Hospitals of Cleveland Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Balls JW; Department of Blood and Marrow Transplant, AdventHealth Hospital, Orlando, FL, USA.
  • Baer L; Stem Cell Transplant Program, University Hospitals of Cleveland Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Smith M; Department of Blood and Marrow Transplant, AdventHealth Hospital, Orlando, FL, USA.
  • Smith T; Department of Blood and Marrow Transplant, AdventHealth Hospital, Orlando, FL, USA.
  • Nelson M; Department of Blood and Marrow Transplant, AdventHealth Hospital, Orlando, FL, USA.
  • de Lima M; Stem Cell Transplant Program, University Hospitals of Cleveland Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Mori S; Department of Blood and Marrow Transplant, AdventHealth Hospital, Orlando, FL, USA.
Leuk Lymphoma ; 61(12): 2839-2849, 2020 12.
Article em En | MEDLINE | ID: mdl-32650686
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos